Fusobacterium nucleatum, rectal cancer and radiotherapy
- PMID: 32629022
- DOI: 10.1016/j.annonc.2020.06.019
Fusobacterium nucleatum, rectal cancer and radiotherapy
Conflict of interest statement
Disclosure EHM is a postdoctoral fellow in Professor Fiona Powrie’s laboratory, which is part of the CRUK Grand Challenge team OPTIMISTICC (C10674/A27140) alongside Dr Paolo Nucifero. TSM has no relevant conflicts of interest, but receives research funding to the institution from Astra Zeneca, Merck KgAa and Psioxus.
Comment on
-
Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.Ann Oncol. 2020 Oct;31(10):1366-1375. doi: 10.1016/j.annonc.2020.06.003. Epub 2020 Jun 20. Ann Oncol. 2020. PMID: 32569727 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
